GSK1265744 Demonstrates Robust In Vitro Activity Against Various Clades of HIV-1

This publication has 13 references indexed in Scilit:

• A Randomized Open-Label Study of 3- Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1–Infected Individuals
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
• Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus
  Science, 2014
• Long-acting injectable antiretrovirals for HIV treatment and prevention
  Current Opinion in HIV and AIDS, 2013
• Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis
  Drugs, 2013
• Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
  Nature, 2012
• Preexposure Prophylaxis for HIV Infection among African Women
  New England Journal of Medicine, 2012
• FDA approves first drug to prevent HIV infection
  BMJ, 2012
• Sequential Deletion of the Integrase (Gag-Pol) Carboxyl Terminus Reveals Distinct Phenotypic Classes of Defective HIV-1
  Journal of Virology, 2011
• Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
  New England Journal of Medicine, 2010
• Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector
  Antimicrobial Agents and Chemotherapy, 2010